Table 2.
Cancers observed and expected, with standardized incidence ratios (SIRs) and 95% confidence intervals (95% CIs)
| Observed | Expected | SIR | 95% CI | ||
|---|---|---|---|---|---|
| All | 644 | 566.3 | 1.14 | 1.05 | 1.23 |
| Hematologic* | 111 | 36.8 | 3.02 | 2.48 | 3.63 |
| Non-Hodgkin Lymphoma | 76 | 17.3 | 4.39 | 3.46 | 5.49 |
| Hodgkin’s Lymphoma | 7 | 3.1 | 2.28 | 0.92 | 4.70 |
| Multiple Myeloma | 10 | 5.3 | 1.88 | 0.90 | 3.46 |
| Leukemia | 18 | 10.3 | 1.75 | 1.04 | 2.76 |
| Breast | 114 | 155.2 | 0.73 | 0.61 | 0.88 |
| Ovary | 13 | 20.2 | 0.64 | 0.34 | 1.10 |
| Cervix | 21 | 16.6 | 1.27 | 0.78 | 1.93 |
| Vagina | 2 | 0.5 | 3.80 | 0.46 | 13.74 |
| Vulva | 7 | 1.9 | 3.78 | 1.52 | 7.78 |
| Endometrial | 12 | 27.2 | 0.44 | 0.23 | 0.77 |
| Lung | 85 | 65.5 | 1.30 | 1.04 | 1.60 |
| Hepatic | 12 | 6.4 | 1.87 | 0.97 | 3.27 |
| Pancreas | 10 | 11.2 | 0.90 | 0.43 | 1.65 |
| Gastric | 14 | 11.8 | 1.19 | 0.65 | 2.00 |
| Colorectal | 51 | 58.2 | 0.88 | 0.65 | 1.15 |
| Thyroid | 24 | 13.7 | 1.76 | 1.13 | 2.61 |
| Bladder | 18 | 14.4 | 1.25 | 0.74 | 1.97 |
| Prostate | 11 | 16.9 | 0.65 | 0.32 | 1.16 |
| Melanoma | 11 | 16.3 | 0.67 | 0.34 | 1.20 |
Hematologic=all lymphomas, leukemias, and multiple myeloma